life-threatening complications. 3 However, the removal of chronically implanted leads, which develop fibrous adhesions with surrounding vessel walls and tissues, could be challenging. To address this issue many extraction techniques have been developed including laser sheaths, mechanical sheaths, or electrosurgical dissection sheaths. [4] [5] [6] [7] A bidirectional rotational mechanical sheath (Evolution RL, Cook medical) has proved to be extremely safe and effective with long implanted leads. 8, 9 However, powered sheaths have been related to higher complication rates, 2 and concerns can be raised about their use in case of recently implanted leads. The treated metal distal tip of Evolution RL allows the system to pass through adhesions but could also damage surrounding tissue. A new bidirectional rotational mechanical sheath TightRail (Spectranetics), with a more flexible shaft that provides high co-axiality with the lead and a dilating blade that remains shielded until activated, is now available. Multicentric data about its safety and efficacy still lacks. The aim of this study was to report our preliminary experience with the TightRail (Spectranetics) sheath for lead extractions at two tertiary care Italian centers.
| ME THODS

| Patients
This is a prospective study that included all patients who underwent a TLE in which the TightRail was used, either alone or in association with other extraction sheath, at two tertiary referral centers: San Raffaele Hospital (Milan, Italy) and Humanitas Gavazzeni Hospital (Brescia, Italy). Indication for TLE included infection and lead malfunction. For each lead, the underlying type (active/passive fixation, single double coil catheters), duration of implant, and fixation modality were recorded. All patients provided a written informed consent before the procedure and the study was approved by the Institutional Committee of Human Research at our Hospital.
| Extraction procedure
All TLE procedures were conducted in the electrophysiology laboratory by two skilled operators (PM and GM), with an experience of more than one thousand of extracted catheters each and ability to perform TLE with a wide range of tools, including laser and rotational sheaths, and performed under general anesthesia or sedation and ECG, pulse oximetry, and arterial blood pressure monitoring, with a cardiothoracic surgeon on standby. 10 A subclavian approach was initially preferred; if the patient was pacemaker (PM) dependent, a temporary right ventricular active fixation lead was placed from the femoral vein. All patients underwent TLE with a standard stepwise approach, as previously described. 11 At first, the leads were dissected free from the scar in the pocket, then simple manual trac- 
F I G U R E 1
The TightRail dilator sheath is composed by an inner and outer shaft and a handled drive mechanism used to rotate the inner shaft
The TightRail dilator sheath is composed by an inner and outer shaft and a handled drive mechanism ( Figure 1 ). The inner shaft (drive shaft) is available in French sizes of 9, 11, and 13, and is able to rotate within the outer shaft. The rotary dilating feature at the tip remains shielded until activated, allowing a safe progression through the vessel. The stationary outer shaft is contained within a polymer jacket and is extremely flexible, enabling to remain coaxial to the lead. The handheld drive mechanism attached to the proximal end of the device is used to rotate the inner shaft. A shorter, stiffer, and more aggressive version of the TightRail, the so-called Sub-C, is available to overcome heavy calcifications under the clavicle, which are not uncommon.
| Outcomes
All patients were monitored for procedure-related complications in the operating room and during hospital stay. Clinical outcomes and adverse events were prospectively monitored at 30 days and 6 months by ambulatory direct visit or phone interview.
| Definitions
Complete procedural success corresponded to the removal of all targeted leads and all lead material from the vascular space, without complication or procedure-related death. Clinical success was defined as the removal of all targeted leads and all lead material from the vascular space or retention of a small portion of the lead that does not negatively impact the outcome goals of the procedure. Any event occurring while the patient was in the operating room and all events related to the procedure occurring within 30 days were classified as intraprocedural complications or postprocedural complications, respectively. 12,13 second procedure during the same hospitalization; after collegial discussion, reimplantation was not performed in four patients. All the leads were extracted using initially the subclavian approach.
| Statistical analysis
| RE SULTS
Twenty patients (76%), because of adherence between the vessel and the first rib, were initially approached with the TightRail Sub-C. 
| D ISCUSS I ON
To the best of our knowledge, this is the first prospective multi- Only two single-center experiences with the TightRail™ have been reported: Aytemir used it in 23 patients with a median time from implantation of 72 months 14 ; compared to this report, in our multicentric experience the mean lead age was higher; Sawhney described successful TLE with TightRail™ in 3 patients. 15 Compared to these previous reports, in our multicentric experience the median lead age was higher, further confirming the possibility to use the TightRail™ also in long-standing, chronically implanted leads.
Moreover, we are the first to describe the use of TightRail Sub-C to exceed the excessive fibrous adhesions or calcification between the vessel and first rib that was previously considered a critical issue about the use of TightRail for lead extraction.
Amount of evidence is available about the new Evolution RL
mechanical sheath that has proven to be safe and effective for long-standing lead extraction in single and multicentric registries. 8, 16 The use of powered sheaths has been shown to be associated with higher procedure related major complications. 2 
| Limitations
The main limitations are represented by the small size of the population studied and by the lack of comparison with other mechanical dilator sheaths. Larger scale randomized studies should be conducted in the future to identify appropriate decision-making and therapeutic strategies to deal with the increasing request of TLE procedures.
| CON CLUS IONS
This initial experience using the TightRail suggests a high safety and efficacy profile for lead extraction when initial fibrous adherence is present.
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